See the DrugPatentWatch profile for restasis
The cost of generic Restasis can vary significantly based on factors such as the pharmacy, insurance coverage, and whether a prescription discount card is used.
How much does generic Restasis typically cost?
Without insurance, a prescription for generic Restasis (cyclosporine ophthalmic emulsion) can range from approximately $50 to over $200 for a 30-day supply. Prices can differ considerably between retail pharmacies. For instance, one source indicates a price around $55 at a particular pharmacy, while another may list it closer to $200. Prices can also fluctuate over time.
What impacts the price of generic Restasis?
Insurance plans play a crucial role in the out-of-pocket cost for generic Restasis. Many insurance providers offer coverage that can reduce the cost to a co-pay, which might range from $10 to $50. However, the specific co-pay amount depends on the details of the individual insurance plan. For those without insurance, or if the medication is not covered by their plan, the full retail price will apply. Prescription discount cards or coupons can also offer savings, potentially bringing the cost down.
When did generic Restasis become available?
The U.S. Food and Drug Administration (FDA) approved the first generic version of Restasis in 2018. This marked the availability of a less expensive alternative to the brand-name drug for treating the signs and symptoms of dry eye disease.
Are there other options besides generic Restasis for dry eye?
Several other prescription eye drops are available for treating dry eye disease, including Xiidra (lifitegrast) and other formulations of cyclosporine. Over-the-counter lubricating eye drops, artificial tears, and punctal plugs are also common treatments. The choice of treatment often depends on the severity of the condition and a healthcare provider's recommendation.
What is the difference between brand-name Restasis and its generic version?
Generic Restasis contains the same active ingredient, cyclosporine, in the same dosage as brand-name Restasis. Regulatory bodies like the FDA require generic drugs to demonstrate bioequivalence to their brand-name counterparts, meaning they are expected to work the same way in the body. While the active ingredients are identical, inactive ingredients may differ, which is generally not significant but could theoretically be a factor for individuals with specific sensitivities.
Sources:
1. https://www.singlecare.com/drugs/cyclosporine-ophthalmic-emulsion/558646
2. https://www.goodrx.com/restasis
3. https://www.goodrx.com/cyclosporine-ophthalmic-emulsion